Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126361931 | 12636193 | 1 | I | 20150616 | 20160809 | 20160809 | PER | SG-GLENMARK PHARMACEUTICALS INC, USA.-2015GMK017914 | GLENMARK | KOH W L, LIU T T. ERYTHEMA ANNULARE CENTRIFUGUM: FOOD FOR THOUGHT. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2015;72 (5 SUPPL. 1):AB47 | 54.00 | YR | F | Y | 0.00000 | 20160809 | OT | SG | SG |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126361931 | 12636193 | 1 | SS | DOXYCYCLINE. | DOXYCYCLINE | 1 | Oral | 100 MG, BID | U | 0 | 100 | MG | BID | ||||||
126361931 | 12636193 | 2 | SS | MOMAETASONE FUROATE/FUSIDIC ACID | FUSIDIC ACIDMOMETASONE FUROATE | 1 | Topical | UNK, BID | U | 0 | OINTMENT | BID | |||||||
126361931 | 12636193 | 3 | PS | BETAMETHASONE. | BETAMETHASONE | 1 | Topical | UNK, BID | U | 78930 | CREAM | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126361931 | 12636193 | 1 | Erythema annulare |
126361931 | 12636193 | 2 | Erythema annulare |
126361931 | 12636193 | 3 | Erythema annulare |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126361931 | 12636193 | Off label use | |
126361931 | 12636193 | Therapeutic response unexpected |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |